Clinical Trial Update: Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial update for ABX-1431 in adults with Tourette Syndrome or Chronic Motor Tic Disorder has completed enrollment and status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motor Tic Disorder
• Tourette Syndrome

Drugs mentioned

• ABX-1431 (ABX-1431)

Snippet

Sponsor: Abide Therapeutics | Conditions: Tourette Syndrome, Motor Tic Disorder | Phase 2 | Status: COMPLETED